Condition
Renin Angiotensin System
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
50%
2 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 4 (2)
Trial Status
Completed3
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT03374449Not ApplicableCompletedPrimary
Impact of Renin-Angiotensin System Inhibitors Continuation on Outcome After Major Surgery
NCT01049646Not ApplicableCompletedPrimary
Interaction of Apelin and Angiotensin in the Systemic Circulation
NCT00674596Phase 4Completed
The Effect of Renin Angiotensin System Blockage (RAS) Blockade On PTX3 Levels In Diabetic Patients With Proteinuria
NCT00517322Phase 4Unknown
Left Atrial Remodelling in Hypertension: Effects of Ramipril or Irbesartan
Showing all 4 trials